SAVANNAH, Ga.—One year after pausing mammography at the onset of the COVID-19 pandemic, most breast cancer patients were still presenting with early-stage disease, but there was already a shift away from earliest stage disease and toward slightly more advanced cancer, according to one institution’s research.
On March 26, 2020, concerned that the risk for potential exposure to the virus outweighed the benefits of mammography, the American Society of Breast Surgeons